Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05176587Withdrawn

Medical and Medico-economic Evaluation Comparing the Follow-up of Patients Undergoing Bariatric Surgery

Role: collaborator

NCT03722212Not ApplicableCompleted

Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test

Role: collaborator

NCT02893527Not ApplicableTerminated

Implementation and Evaluation of a Social Journey Accompanied in Breast Cancer Diagnosis (EPARS SEIN)

Role: collaborator

NCT02208999Completed

Follow-up of Post-spinal Implantable Neurostimulator PRECISION®

Role: lead

All 4 trials loaded